LinkedIn Insight Tag Medical Data Collection Dismissed by US Judge

• A federal judge has largely dismissed a privacy lawsuit against LinkedIn over its Insight Tag feature.
• The plaintiffs alleged that Insight Tag collected sensitive medical data without their consent.
• The judge found that LinkedIn had thoroughly disclosed its tracking activity, but was concerned about the collection of medical information.
• This ruling may have implications for lawyers advising clients on similar tracking technologies and disclosure practices.

The issue of health information being shared via tracking technology is so well known in the technology industry that LinkedIn should have known its Insight Tag was likely collecting personal health information

A federal judge has largely dismissed a privacy lawsuit against LinkedIn over its Insight Tag feature. The plaintiffs alleged that Insight Tag collected sensitive medical data without their consent, but Senior U.S. District Judge Edward Davila found that the company had thoroughly disclosed its tracking activity. However, the judge did not grant a full dismissal due to concerns about the collection of medical information. This ruling may have implications for lawyers advising clients on similar tracking technologies and disclosure practices.

The Insight Tag feature links actions on third-party advertiser websites to specific LinkedIn profiles. While the company's disclosures were deemed sufficient, the judge noted that some health care sites using Insight Tag did not clearly disclose their data-sharing practices.

This case is part of a growing trend of lawsuits targeting companies for collecting and monetizing sensitive user data. In October, Judge Davila declined to dismiss a similar medical privacy suit brought against LinkedIn over its Insight Tag feature. The plaintiffs in this case alleged that LinkedIn had intercepted personal health information and used it for targeted advertising.

The judge's ruling highlights the importance of clear disclosure practices in the technology industry. While LinkedIn's disclosures were deemed sufficient, the court noted that some healthcare sites using Insight Tag did not provide adequate transparency about their data-sharing practices.

This ruling has significant implications for lawyers advising clients on similar tracking technologies and disclosure practices. The judge's decision may set a precedent for future cases involving the collection and use of sensitive user data. As companies continue to rely on tracking technologies like Insight Tag, they must ensure that their disclosures are clear and transparent.

The case also highlights the need for greater regulation and oversight in the technology industry. With more consumers becoming aware of the risks associated with data collection, companies must adapt to changing consumer expectations and take steps to protect user privacy.

Lawyers should watch for the precedent set by this ruling, which may impact their clients' use of similar tracking technologies and disclosure practices.

Source: Original reporting via Courthouse News